Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study

BACKGROUND/AIMS: Non-selective beta blockers (NSBBs) are currently the only accepted regimen for preventing portal hypertension (PHT)-related complications. However, the effect of NSBBs is insufficient in many cases. Bacterial translocation (BT) is one of the aggravating factors of PHT in cirrhosis;...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Yoo Li, Kim, Moon Young, Jang, Yoon Ok, Baik, Soon Koo, Kwon, Sang Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593333/
https://www.ncbi.nlm.nih.gov/pubmed/28651304
http://dx.doi.org/10.5009/gnl16478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593333/
https://www.ncbi.nlm.nih.gov/pubmed/28651304
http://dx.doi.org/10.5009/gnl16478

Ejemplares similares